This website is intended for healthcare professionals only.

Newsletter      
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

More news

medicinal cannabis and driving performance
Medicinal cannabis does not impair driving performance
REACT-1 interim data
Latest REACT-1 study data suggest COVID-19 rates are falling
mutations in COVID
No increased risk for transmission with COVID-19 mutations
baricitinib and remdesivir
FDA approves baricitinib remdesivir combination for COVID-19
vigorous physical activity
Making physical activity more vigorous reduces all-cause mortality
thromboembolism in COVID
Thromboembolism common in COVID-19 and associated with an increased mortality risk
chronic urticaria
Uncertainty over the efficacy of up-dosing antihistamine in chronic urticaria
vital shedding and viable COVID
Prolonged viral shedding not associated with viable COVID-19 virus
brodalumab in PsA
Brodalumab significantly improves symptoms in psoriatic arthritis


Popular articles

Aspirin use associated with improved survival but only for bladder and breast cancer
Metformin use in diabetes protective against COVID-19-related mortality
Low levels of alcohol intake linked to greater risk of atrial fibrillation
Bimagrumab leads to significant fat loss in obese, type 2 diabetic patients
Higher convalescent plasma antibody titre levels associated with lower risk of death in COVID-19




 
Hospital Healthcare Europe
 
LinkedIn Logo Footer  Twitter Logo Footer

Ⓒ Cogora 2021
Cogora Limited, 140 London Wall, London EC2Y 5DN, Registered in the United Kingdom. Reg. No. 2147432

Hospital Healthcare Europe
HOPE Logo Footer